EA2192
OPEN TO ACCRUAL
APOLLO: PII Adjuvant Olaparib vs Placebo for Resected Pancreatic Cancer with BRCA1/2 or PALB2
NCI10464
OPEN TO ACCRUAL
Ph1 Olaparib in Combo with durvalumab & radiation following 1st line chemo locally adv unresec panc
UW24025
OPEN TO ACCRUAL
A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors
UW24051
OPEN TO ACCRUAL
Phase 1/2 Basket Study of MK-2870 in GI Cancers